As Medicines Co (MDCO) Shares Rose, Rhenman & Partners Asset Management Ab Has Boosted …

It has underperformed by 8.36% the S&P500. Some Historical MDCO News: 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 …

The Medicines Company (NASDAQ:MDCO) Logo

Rampart Investment Management Company Llc increased its stake in Bank Amer Corp (BAC) by 19.94% based on its latest 2019Q2 regulatory filing with the SEC. Rampart Investment Management Company Llc bought 27,225 shares as the company’s stock rose 1.39% . The institutional investor held 163,790 shares of the major banks company at the end of 2019Q2, valued at $4.75M, up from 136,565 at the end of the previous reported quarter. Rampart Investment Management Company Llc who had been investing in Bank Amer Corp for a number of months, seems to be bullish on the $284.83 billion market cap company. The stock increased 1.26% or $0.4 during the last trading session, reaching $31.67. About 12.59 million shares traded. Bank of America Corporation (NYSE:BAC) has declined 2.01% since November 1, 2018 and is downtrending. It has underperformed by 2.01% the S&P500. Some Historical BAC News: 01/05/2018 – Bank Of America: Two-Thirds of Boston Entrepreneurs Foresee Long-Term Growth – Highest Since 2015 – Tuesday, May 1, 2018 9:00; 10/05/2018 – Momenta Presenting at Bank of America Conference May 17; 10/04/2018 – EX-BOFA BRAZIL EMPLOYEES ARE SAID TO BUILD NEW EQUITY FUND; 24/05/2018 – Cardlytics Presenting at Bank of America Conference Jun 7; 14/05/2018 – Juniper Presenting at Bank of America Conference Jun 5; 16/04/2018 – BANK OF AMERICA 1Q FICC TRADING REV. EX-DVA $2.54B, EST. $2.96B; 16/05/2018 – Arcos Dorados Presenting at Bank of America Conference May 30; 16/05/2018 – Arista Networks Presenting at Bank of America Conference Jun 5; 24/04/2018 – Service Corp Presenting at Bank of America Conference May 16; 11/05/2018 – NORTH SEA MIDSTREAM SAID TO BE ADVISED BY BANK OF AMERICA

Rhenman & Partners Asset Management Ab increased its stake in Medicines Co (MDCO) by 53.85% based on its latest 2019Q2 regulatory filing with the SEC. Rhenman & Partners Asset Management Ab bought 70,000 shares as the company’s stock rose 12.70% . The institutional investor held 200,000 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $7.29 million, up from 130,000 at the end of the previous reported quarter. Rhenman & Partners Asset Management Ab who had been investing in Medicines Co for a number of months, seems to be bullish on the $4.15B market cap company. The stock decreased 0.40% or $0.21 during the last trading session, reaching $52.28. About 119,751 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 8.36% since November 1, 2018 and is downtrending. It has underperformed by 8.36% the S&P500. Some Historical MDCO News: 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; 23/03/2018 – EU MEDICINES AGENCY RECOMMENDS APPROVAL OF SANDOZ’S BIOSIMILAR DRUG FOR TREATMENT OF RHEUMATOID ARTHRITIS, CROHN’S DISEASE, ULCERATIVE COLITIS, ETC; 24/05/2018 – The Medicines Patent Pool Presents New Five-Year Strategy for Improving Access to Priority Treatments in Developing Countries; 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness lmmunometabolism to Develop Precision Medicines for Immune-Mediated Diseases; 17/05/2018 – Amgen and Novartis: European Medicines Agency Application for Aimovig Is Under Review; 15/03/2018 – Mena Report: Pnsp 2018-3-52: Exclusive Medicines Of The Firm Novartis Farmacutica Espaa, Sl For The Pharmacy Service Of The; 20/03/2018 – BIOPHYTIS SA ALBPS.PA – FILED FOR ORPHAN DRUG DESIGNATION WITH THE EUROPEAN MEDICINES AGENCY (EMA); 08/05/2018 – ASTRAZENECA PLC AZN.L – EUROPEAN MEDICINES AGENCY (EMA) HAS APPROVED LYNPARZA (OLAPARIB) TABLETS; 26/03/2018 – Alnylam Receives European Medicines Agency PRIME Designation for Accelerated Assessment of Lumasiran, an Investigational RNAi; 13/03/2018 – IQVIA Institute for Human Data Science Study: 10 Predictions for Innovation, Spending Drivers and Societal Value of Medicines

Rhenman & Partners Asset Management Ab, which manages about $907.85 million US Long portfolio, decreased its stake in Esperion Therapeutics Inc (NASDAQ:ESPR) by 67,674 shares to 412,093 shares, valued at $19.17M in 2019Q2, according to the filing. It also reduced its holding in Novocure Ltd Reg by 88,748 shares in the quarter, leaving it with 365,899 shares, and cut its stake in Arena Pharmaceuticals Inc Reg.

More notable recent The Medicines Company (NASDAQ:MDCO) news were published by: Finance.Yahoo.com which released: “The Daily Biotech Pulse: Biogen Alzheimer’s Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug – Yahoo Finance” on October 22, 2019, also Benzinga.com with their article: “The Daily Biotech Pulse: FDA Panel Backs Shionogi’s Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO – Benzinga” published on October 17, 2019, Finance.Yahoo.com published: “Hedge Funds Have Never Been This Bullish On The Medicines Company (MDCO) – Yahoo Finance” on October 21, 2019. More interesting news about The Medicines Company (NASDAQ:MDCO) were released by: Benzinga.com and their article: “Stocks That Hit 52-Week Highs On Monday – Benzinga” published on October 21, 2019 as well as Benzinga.com‘s news article titled: “Stocks That Hit 52-Week Highs On Thursday – Benzinga” with publication date: October 17, 2019.

Since May 20, 2019, it had 2 insider buys, and 0 insider sales for $16.26 million activity.

Investors sentiment increased to 1.66 in 2019 Q2. Its up 0.40, from 1.26 in 2019Q1. It increased, as 23 investors sold MDCO shares while 45 reduced holdings. 40 funds opened positions while 73 raised stakes. 97.20 million shares or 11.89% less from 110.32 million shares in 2019Q1 were reported. Comerica Bank & Trust accumulated 0.03% or 110,570 shares. Jpmorgan Chase & reported 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Moreover, Cim Mangement Inc has 0.19% invested in The Medicines Company (NASDAQ:MDCO). Riverhead Capital Mgmt Ltd Liability Co invested in 14,606 shares or 0.02% of the stock. State Street holds 3.64 million shares. Prudential Financial Inc stated it has 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO). State Of Tennessee Treasury Department, Tennessee-based fund reported 25,940 shares. Royal Bank & Trust Of Canada reported 1,414 shares. Pub Sector Pension Inv Board reported 153,713 shares. Rafferty Asset Mngmt Limited Liability Corp stated it has 141,979 shares or 0.09% of all its holdings. Macquarie Group Ltd invested 0.08% of its portfolio in The Medicines Company (NASDAQ:MDCO). Proshare Advisors Lc accumulated 32,343 shares or 0.01% of the stock. Qs Limited Liability Com reported 6,000 shares. 4.65 million were accumulated by Westfield Capital Lp. Hanseatic Mngmt owns 67 shares.

More notable recent Bank of America Corporation (NYSE:BAC) news were published by: Seekingalpha.com which released: “SocGen turns bear on BofA – Seeking Alpha” on October 29, 2019, also Investorplace.com with their article: “3 Wild Stocks to Trade This Week – Investorplace.com” published on October 15, 2019, Seekingalpha.com published: “Bank of America Q3 2019 Earnings Preview – Seeking Alpha” on October 15, 2019. More interesting news about Bank of America Corporation (NYSE:BAC) were released by: Investorplace.com and their article: “This Employee Benefits Push Could Pay off Big for BAC Stock – Investorplace.com” published on October 07, 2019 as well as Fool.com‘s news article titled: “A Rundown of Third-Quarter Bank Earnings and More – Motley Fool” with publication date: October 22, 2019.

Rampart Investment Management Company Llc, which manages about $668.66 million and $847.71 million US Long portfolio, decreased its stake in Lowes Cos Inc (NYSE:LOW) by 6,437 shares to 33,438 shares, valued at $3.37 million in 2019Q2, according to the filing. It also reduced its holding in Unitedhealth Group Inc (NYSE:UNH) by 1,651 shares in the quarter, leaving it with 25,352 shares, and cut its stake in Union Pacific Corp (NYSE:UNP).

Bank of America Corporation (NYSE:BAC) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts